Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

N Engl J Med. 2023 Mar 9;388(10):954-955. doi: 10.1056/NEJMc2216470.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Heart Disease Risk Factors
  • Humans
  • Risk Factors
  • Triglycerides

Substances

  • Triglycerides
  • (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid